Nkarta, Inc.
Status: Publicly traded
Direct answer
Nkarta, Inc. is publicly traded on NASDAQ under the ticker NKTX.
Nkarta, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to advancing and marketing cell-based treatments for cancer. Their innovative cellular immunotherapy strategy outfits natural killer (NK) cells with chimeric antigen receptors (CARs) on their surface, allowing these cells to pinpoint particular proteins or antigens found on the exterior of tumor cells. The company's primary...
Can you invest in Nkarta, Inc.?
Yes. Nkarta, Inc. is publicly traded on NASDAQ under the ticker NKTX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Nkarta, Inc.
Detailed equity research is provided by MarketSnap.